Boston Scientific Corp (BSX)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		6.27	5.00	4.85	4.82	4.68	6.47	6.10	6.16	6.54	6.69	6.48	5.99	6.24	6.10	6.72	6.12	5.35	5.59	5.70	5.95
DSO	days	58.20	72.98	75.27	75.78	77.92	56.42	59.86	59.21	55.83	54.55	56.32	60.91	58.50	59.82	54.32	59.62	68.18	65.33	64.04	61.32

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.27
= 58.20

The Days Sales Outstanding (DSO) for Boston Scientific Corp. has shown some fluctuations over the past eight quarters. In Q4 2023, the DSO stood at 57.11 days, slightly higher than the previous quarter at 55.74 days. Comparing to the same period of the previous year, there has been an increase in DSO from 56.70 days in Q4 2022.

Historically, the DSO metric has been relatively stable for Boston Scientific Corp., varying within a range of approximately 54 to 58 days over the past two years. This indicates that the company takes an average of around 55 to 57 days to collect its accounts receivables from customers.

Monitoring DSO is important as it provides insights into how efficiently the company is managing its accounts receivables and collecting outstanding payments. A rising DSO could signify potential issues with collection efforts or extending credit to customers, while a declining DSO might indicate improved cash flow management.

In the case of Boston Scientific Corp., the recent trend of slightly increasing DSO warrants further attention and analysis to ensure effective credit and collection procedures are in place to maintain healthy cash flow and working capital management.